Genetic studies of extra-early provitamin-A maize inbred lines and their hybrids in multiple environments

Open Access Article; Published online: 25 Sept 2019Vitamin A deficiency, drought, low soil nitrogen (low N) and Striga hermonthica parasitism of maize (Zea mays L.) cause malnutrition and food insecurity in sub-Saharan Africa. The objectives of this study were to determine combining abilities of extra-early provitamin A (PVA) lines, classify them into heterotic groups (HGs), identify testers, and determine yield stability of hybrids under contrasting environments in two trials. In trial 1, 20 extra-early PVA lines were inter-mated in a diallel mating scheme to obtain 190 F1 hybrids. The 190 F1 hybrids plus six checks were tested under Striga infestation, drought, and stress-free environments in Nigeria from 2015 to 2017. In trial 2, 35 extra-early yellow hybrids were evaluated under low-N, Striga-infested and stress-free environments in 2018. Provitamin A concentrations of 23.98 and 22.56 μg g-1 were obtained for TZEEIOR 202 and TZEEIOR 205. TZEEIOR 197 × TZEEIOR 205 (20.1 μg g-1) and TZEEIOR 202 × TZEEIOR 205 (22.7 μg g-1) contained about double the PVA level of the commercial check, TZEEI 58 × TZEE-Y Pop STR C5 (11.4 μgg-1). Both general (GCA) and specific (SCA) combining ability variances were statistically significant for most agronomic traits, although GCA was much larger than SCA effects, indicating that additive genetic effects primarily controlled the inheritance of those traits. TZEEIOR 97 and TZEEIOR 197 were identified as inbred testers. TZEEIOR 197 × TZEEIOR205 (20.1 μg g-1) was identified as a single-cross tester as well as the most stable and highest-yielding hybrid across environments. TZEEIOR 202 and TZEEIOR 205 should be invaluable resources for breeding for high PVA. PVA level was independent of hybrid yield potential, indicating that selection of superior hybrids with elevated PVA levels should be feasible

Gathering garbage or going green? Shifting social perspectives to empower individuals with special needs

Abstract Digital technologies are increasingly used with individuals with special needs for skill-building, social inclusion, and empowerment. However, different stakeholders involved in raising an individual with special needs have different and sometimes conflicting understanding of empowerment and motivations towards it. Using an empowerment framework, we collaboratively analyzed and critically reflected on the design and outcomes of three user studies conducted at a special needs school in New Delhi, India. The studies focused on learning how to make compost out of everyday kitchen waste, to assemble a solar lantern, and to buy groceries from a local store. Findings from the analysis provide insights into the complex socio-cultural conditions that enable, and in some cases limit, empowerment of individuals in an underserved and special needs context. We contribute to discussions on empowerment of children through design and use of digital technologies

Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a leading cause of cancer death. The multikinase inhibitor sorafenib is widely used for systemic therapy in advanced HCC. Sorafenib might affect epoxyeicosanoids, as it is also a potent inhibitor of the soluble epoxide hydrolase (sEH), which catalyzes the conversion of epoxides derived from long-chain polyunsaturated fatty acids (PUFAs), such as arachidonic acid (AA) and omega-3 docosahexaenoic acid (DHA), into their corresponding diols. Experimental studies with AA-derived epoxyeicosatrienoic acids (EETs) showed that they can promote tumor growth and metastasis, while DHA-derived 19,20-epoxydocosapentaenoic acid (19,20-EDP) was shown to have anti-tumor activity in mice. In this pilot study, we assessed the effect of sorafenib treatment on the presence of lipid mediators, such as EETs, in blood of the patients with HCC using the lipidomics technology. We found a significant increase in 11,12-EET and 14,15-EET levels in HCC patients treated with sorafenib. Furthermore, while not significant in this small sample set, the data presented indicate that sorafenib can also increase the level of omega-3 DHA-derived 19,20-EDP. While the effect on EETs might hamper the anti-tumor effect of sorafenib, we hypothesize that supplementation of DHA in sorafenib-treated HCC patients could increase the level of 19,20-EDP and thereby enhance its anti-tumor effect

Socio-technical aspirations for children with special needs:a study in two locations — India and Finland

Abstract Society’s expectations and assistance for children with special needs is rooted in its cultural, societal, and political backdrop. Previous work on the role of culture on assistive or adaptive technology design for children with special needs identified a three-part framework: lifestyle, socio-technical infrastructure, and monetary and informational resources. Through our work in India, we proposed a fourth dimension to this framework: socio-technical aspirations. We defined socio-technical aspirations as the individual- or community-driven ambition and desire to own or use a specific technology for personal benefit or societal acceptance or both. In Finland, we interviewed four parents of children enrolled in a rehabilitation program, with the aim to understand their expectations from and current usage of technology. Findings from Finland reveal a desire for technology for children with special needs to be more engaging than what is currently available. We also identified several attributes that can contribute to socio-technical aspirations in a given context, including but not limited to: the level of inclusiveness supported in the school, which directly affects how technology is viewed with respect to the social acceptance it provides; the socio-technical aspirations of the child and how they are perceived and met by the parents and teachers; and previous technology experience of the various stakeholders involved in raising a child with special needs, which determines their attitude toward technology for not only for themselves but also for the child. In this article, we validate the dimension of socio-technical aspirations to strengthen our case for incorporating stakeholder’s socio-technical aspirations for technology designed or adapted for children with special needs

Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a leading cause of cancer death. The multikinase inhibitor sorafenib is widely used for systemic therapy in advanced HCC. Sorafenib might affect epoxyeicosanoids, as it is also a potent inhibitor of the soluble epoxide hydrolase (sEH), which catalyzes the conversion of epoxides derived from long-chain polyunsaturated fatty acids (PUFAs), such as arachidonic acid (AA) and omega-3 docosahexaenoic acid (DHA), into their corresponding diols. Experimental studies with AA-derived epoxyeicosatrienoic acids (EETs) showed that they can promote tumor growth and metastasis, while DHA-derived 19,20-epoxydocosapentaenoic acid (19,20-EDP) was shown to have anti-tumor activity in mice. In this pilot study, we assessed the effect of sorafenib treatment on the presence of lipid mediators, such as EETs, in blood of the patients with HCC using the lipidomics technology. We found a significant increase in 11,12-EET and 14,15-EET levels in HCC patients treated with sorafenib. Furthermore, while not significant in this small sample set, the data presented indicate that sorafenib can also increase the level of omega-3 DHA-derived 19,20-EDP. While the effect on EETs might hamper the anti-tumor effect of sorafenib, we hypothesize that supplementation of DHA in sorafenib-treated HCC patients could increase the level of 19,20-EDP and thereby enhance its anti-tumor effect.</jats:p